Founded Year

2016

Stage

Series D | Alive

Total Raised

$256.06M

Valuation

$0000 

Last Raised

$142M | 5 mos ago

Revenue

$0000 

Mosaic Score

+50 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Truepill

Truepill offers an online pharmacy that provides fulfillment through its API, telehealth services, patient-facing brands, and solutions for health brands, pharmaceutical manufacturers, and health plan providers.In 2021, it also debuted two new core services, telehealth and diagnostics, alongside the company's pharmacy service. Truepill also offers a virtual pharmacy, which serves as a white-labeled pharmacy e-commerce platform for others.

Truepill Headquarter Location

3121 Diablo Ave

Hayward, California, 94545,

United States

833-860-1057

Latest Truepill News

Truepill taps Sid Viswanathan as next CEO and other digital health hires

Mar 2, 2022

Also: Dr. Jay Bhatt becomes executive director of Deloitte Center for Health Solutions, and Owkin names two new executives. Photo: Hero Images Inc/Getty Images  Truepill has tapped Sid Viswanathan as its next CEO. This news comes after the digital pharmacy announced a $142 million funding deal in October . A cofounder of the company, Viswanathan started Truepill in 2016. Since then he served as the company's president. In this new position, he will handle day-to-day operations. He is taking over for fellow cofounder Umar Afridi, who will continue to have involvement with the company as a member of the board of directors. Previously Viswanathan served in Johnson & Johnson's Global Operations Leadership Development program and founded CardMunch. "From the very beginning, our vision has been to create a world where healthcare is accessible and convenient for everyone," Viswanathan said in a statement. “I’m honored to continue deepening Truepill’s work, partnering with industry leading organizations to create solutions that raise the bar for consumer expectations and empower everyone with access to the care they deserve.” Dr. Jay Bhatt was named the executive director of the Deloitte Center for Health Solutions and the Deloitte Health Equity Institute. Bhatt is coming from the American Hospital Association, where he served as the senior vice president and chief medical officer. Previously Bhatt was on the Northwestern Medicine faculty and served as the chief health officer at the Illinois Health and Hospital Association. "Growing up, I had a front-row seat to the challenges that many people face in disadvantaged communities, and these early life experiences convinced me not just to become a doctor, but to become someone who could meet the challenge of treating diverse populations, serving underserved neighborhoods, and helping communities and organizations change their future," Bhatt said in a statement. "I am excited to join an organization with a strong legacy of progress, execution and impact, and one with a mission that reflects my values and aspirations to transform the health of our communities and do it at scale." French artificial intelligence company Owkin named Dr. Vassili Soumelis as its next chief medical officer and Eric Durand as its SVP of data science. Soumelis is a professor at Université de Paris, coordinator of ImmunAID and a practicing physician. Durand is coming to Owkin after serving as director of data science at Novartis. His new duties will include overseeing data science activities at the company. “I was struck early on by the quality and the innovative nature of Owkin’s work," Durand said in a statement. "Combined with the incredible data asset the company is building through its federated platform, I believe Owkin is uniquely positioned to make a lasting impact on patients. "Helping to bring the best analytics to impact drug discovery has been my goal for many years, and it is hard for me to imagine a better place than Owkin for furthering this mission. I can’t wait to get started.”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Truepill

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Truepill in 4 CB Insights research briefs, most recently on Dec 8, 2021.

Expert Collections containing Truepill

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Truepill is included in 10 Expert Collections, including E-Commerce.

E

E-Commerce

9,289 items

U

Unicorns- Billion Dollar Startups

1,066 items

P

Pharma Supply Chain

1,357 items

D

Digital Health 150

450 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

D

Diabetes

1,750 items

D

Digital Health

12,708 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Truepill Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Truepill Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.